Increased circulating products of lipid peroxidation in patients with alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 1, 1998, Pages 192-196

  Aleynik, Semyon I ^a   Leo, Maria Anna ^a   Aleynik, Maria K ^a   Lieber, Charles S ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

4 hydroxynonenal; Alcohol; F2 isoprostanes; Lipid peroxidation; Liver disease

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; ISOPROSTANE IPF2 ALPHA 1; UNCLASSIFIED DRUG;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; BILIARY EXCRETION; CLINICAL ARTICLE; CONFERENCE PAPER; DIAGNOSTIC VALUE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; PATHOPHYSIOLOGY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; REGULATORY MECHANISM;

HEPATITIS C VIRUS;

EID: 0031911322     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03637.x     Document Type: Conference Paper

References (30)

1. Geesin JC, Hendricks LJ, Gordon JS, Berg RA: Modulation of collagen synthesis by growth factors: The role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 289:6-11, 1991
2. Parola M, Pinzani M, Casini A, Leonarduzzi G, Marra F, Caligiuri A, Ceni E, Biondi P, Poli G, Dianzani MU: Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2, 3-nonenal and other 4-hydroxy-2, 3-alkenals is related to their molecular structure. Biochem Biophys Res Commun 222:261-264, 1996
3. Suematsu T, Matsumura T, Sato N, Miyamoto T, Ooka T, Kamada T, Abe H: Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res 5:427-430, 1981
4. Shaw S, Rubin KP, Lieber CS: Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation. Dig Dis Sci 28:585-589, 1983
5. Letteron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Degott C, Benhaumou JP, Pessayre D: Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut 34:409-414, 1993
6. Clot P, Tabone M, Arico S, Albano E: Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 35:1637-1643, 1994
7. Inomata T, Rao GA, Tsukamoto H: Lack of evidence for increased lipid peroxidation in ethanol-induced centrilobular necrosis of rat liver. Liver 7:233-239, 1987
8. Mazzanti R, Moscarella S, Bensi G, Altavilla E, Gentilini P: Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and nonalcoholic liver disease. Alcohol Alcohol 24:121-128, 1989
9. Gutteridge JM, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135, 1990
10. Draper HH, Hadley M: Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol 186:421-431, 1990
11. Thompson S, Smith MT: Measurement of diene conjugated form of linoleic acid in plasma by high performance liquid chromatography: A questionable noninvasive assay for free radical activity? Chem Biol Interact 55:357-366. 1985
12. Situnayake RD, Crump BJ, Thurnham DI, Davies JA, Gearty J, Davis M: Lipid peroxidation and hepatic antioxidant in alcoholic liver disease. Gut 31:1311-1317, 1990
13. Dormandy TL: Diene conjugation in chronic alcoholics, in Normann R, Ribiere C, Rouach (eds): Alcohol toxicity and free radical mechanisms. Oxford, Pergamon Press, 1988, pp 55-59
14. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation. J Clin Invest 90:2502-2507, 1992
15. Aleynik SI, Leo MA, Ma X, Aleynik MK, Lieber CS: Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 26:554-561,1997
16. Lieber CS, Leo MA, Aleynik SI, Aleynik MK, DeCarli LM: Polyenylphosphatidyl-choline decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res 21:375-379, 1997
17. 2-isoprostanes) in hepatorenal syndrome. J Lipid Mediat 6:417-420, 1993
18. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332:1198-1203, 1995
19. 2-isoprostanes and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders. Am J Gastroenterol 92:2069-2072, 1997
20. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89:10721-10725, 1992
21. Esterbauer H, Zollner H: Methods for determination of aldehydic lipid peroxidalion products. Free Radic Biol Med 7:197-203, 1989
22. Van Kuijk FJGM, Thomas DW, Stephens RJ, Dratz EA: Occurrence of 4-hydroxyalkenals in rat tissue determined as pentafluorobenzyl oxime derivatives by gas chromatography-mass spectroscopy. Biochem Biophys Res Commun 139:144-149, 1986
23. 2-isoprostanes produced by noncyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 233:163-174, 1994
24. van Kuijk FJGM, Siakotos AN, Fong LG, Stephens RJ, Thomas DW: Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal Biochem 224:420-424, 1995
25. Snedecor GW, Cochran WG: Statistical Methods, ed 7. Ames, Iowa, Iowa State University Press, 1980, pp 215-230
26. Koterov AN, Shilina NM: Effect of zinc-metallothionein on lipid peroxidation in blood and in mouse liver in acute alcoholic intoxication. Ukr Biokhim Zh 67:80-87, 1995
27. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU: Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact, 65:233-234, 1988
28. Cederbaum AI, Dicker E, Rubin E, Cohen G: The effect of dimethylsulfoxide and other hydroxyl radical scavengers on the oxidation of ethanol by rat liver microsomes. Biochem Biophys Res Comm 78:1254-1262, 1977
29. Ohnishi K, Lieber CS: Respective role of superoxide and hydroxyl radical in the activity of reconstituted microsomal ethanol-oxidizing system. Arch Biochem Biophys 191:798-803, 1978
30. Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS: Hepatitis C virus antibody in alcoholic patients. Association with portal and/or lobular hepatitis. Arch Intern Med 153:965-969, 1993